OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3%

OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% was reported 6990 times

OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTERIOR SEGMENT ISCHAEMIA 6 0.3158
1 FIBRIN 9 0.2093
2 LARYNGEAL HAEMATOMA 11 0.1642
3 KERATITIS FUNGAL 30 0.1442
4 TYPE 2 LEPRA REACTION 25 0.1337
5 CONJUNCTIVAL BLEB 5 0.0926
6 PERSISTENT LEFT SUPERIOR VENA CAVA 7 0.0654
7 PSYCHOTIC DISORDER DUE TO A GENERAL MEDICAL CONDITION 11 0.0611
8 CORNEAL INFILTRATES 17 0.0541
9 CORNEAL DEPOSITS 38 0.0511
10 DELUSION OF REFERENCE 7 0.0504
11 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 9 0.0495
12 ANTERIOR CHAMBER FIBRIN 5 0.0388
13 CORNEAL PERFORATION 24 0.0380
14 RENAL NECROSIS 8 0.0367
15 TOXIC ANTERIOR SEGMENT SYNDROME 37 0.0339
16 CORNEAL GRAFT REJECTION 7 0.0333
17 CORNEAL SCAR 16 0.0318
18 CORNEAL THINNING 8 0.0311
19 HYPOPYON 24 0.0290
20 BONE METABOLISM DISORDER 8 0.0266
21 RECTAL SPASM 6 0.0260
22 FACTOR V INHIBITION 5 0.0258
23 ANTERIOR CHAMBER FLARE 6 0.0258
24 ANTERIOR CHAMBER CELL 18 0.0252
25 PERIORBITAL PAIN 20 0.0236
26 EYE ABSCESS 7 0.0230
27 CORNEAL EPITHELIUM DEFECT 13 0.0224
28 ANTICOAGULATION DRUG LEVEL INCREASED 7 0.0218
29 CORNEAL EROSION 11 0.0204
30 PROSTATIC PAIN 8 0.0196
31 GINGIVAL ULCERATION 14 0.0186
32 CORNEAL TRANSPLANT 14 0.0179
33 CORNEAL OEDEMA 39 0.0174
34 PROTHROMBIN TIME RATIO DECREASED 10 0.0160
35 EYELID PAIN 32 0.0157
36 THERAPEUTIC PRODUCT CROSS-REACTIVITY 14 0.0157
37 LAGOPHTHALMOS 6 0.0147
38 TENDON DISCOMFORT 11 0.0146
39 TENDON PAIN 110 0.0145
40 OTITIS MEDIA CHRONIC 6 0.0143
41 LENTICULAR OPACITIES 6 0.0137
42 PELVIC HAEMATOMA 6 0.0136
43 ANTERIOR CHAMBER INFLAMMATION 8 0.0134
44 GENERALISED BULLOUS FIXED DRUG ERUPTION 5 0.0134
45 CHRONIC FATIGUE SYNDROME 18 0.0129
46 UPPER AIRWAY OBSTRUCTION 11 0.0124
47 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 40 0.0123
48 NON-CARDIOGENIC PULMONARY OEDEMA 13 0.0123
49 SUDDEN INFANT DEATH SYNDROME 6 0.0122
50 ENDOPHTHALMITIS 71 0.0118
51 CORNEAL OPACITY 16 0.0117
52 ULCERATIVE KERATITIS 32 0.0117
53 HYPHAEMA 6 0.0115
54 EYE ULCER 6 0.0104
55 RETINAL PIGMENT EPITHELIAL TEAR 7 0.0101
56 RETINAL VASCULITIS 12 0.0101
57 PROSTATITIS 30 0.0098
58 VASCULITIS NECROTISING 7 0.0098
59 LARYNGEAL DISORDER 7 0.0097
60 INTRAOCULAR PRESSURE DECREASED 5 0.0095
61 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 10 0.0094
62 BLADDER IRRITATION 6 0.0093
63 VASCULAR PURPURA 13 0.0093
64 OTITIS EXTERNA 11 0.0090
65 TENDON DISORDER 58 0.0089
66 MUCOSAL EROSION 8 0.0088
67 HYPERPARATHYROIDISM SECONDARY 22 0.0088
68 VITREOUS OPACITIES 7 0.0083
69 TENDONITIS 128 0.0083
70 CROSS SENSITIVITY REACTION 8 0.0082
71 CORNEAL DISORDER 18 0.0082
72 SMALL FIBRE NEUROPATHY 6 0.0081
73 PERIODONTAL DISEASE 11 0.0078
74 NEPHROGENIC ANAEMIA 36 0.0078
75 DIARRHOEA INFECTIOUS 6 0.0076
76 EXTENSOR PLANTAR RESPONSE 7 0.0076
77 CORNEAL ABRASION 10 0.0073
78 COARCTATION OF THE AORTA 7 0.0072
79 KERATITIS 22 0.0072
80 EYE ROLLING 5 0.0071
81 ACQUIRED HAEMOPHILIA 7 0.0070
82 RASH MORBILLIFORM 19 0.0068
83 MOTION SICKNESS 13 0.0067
84 CYTOLYTIC HEPATITIS 22 0.0066
85 ORCHITIS 7 0.0065
86 EYE PAIN 360 0.0064
87 EYELID IRRITATION 16 0.0064
88 OSTEITIS 16 0.0063
89 HYPERMETROPIA 6 0.0063
90 SCLERITIS 10 0.0062
91 RETINAL DEGENERATION 8 0.0062
92 ILLUSION 10 0.0060
93 VITRITIS 11 0.0059
94 TYMPANIC MEMBRANE PERFORATION 10 0.0059
95 INTRA-ABDOMINAL HAEMORRHAGE 14 0.0059
96 FIXED ERUPTION 10 0.0058
97 OTORRHOEA 10 0.0057
98 ATROPHY 11 0.0056
99 EYE INFLAMMATION 53 0.0055
100 VITREOUS HAEMORRHAGE 15 0.0054
101 IMMUNE RECONSTITUTION SYNDROME 7 0.0054
102 METAMORPHOPSIA 10 0.0054
103 TESTICULAR PAIN 17 0.0054
104 OCULAR DISCOMFORT 60 0.0053
105 SUPERINFECTION 8 0.0053
106 FOREIGN BODY SENSATION IN EYES 34 0.0053
107 DYSAESTHESIA 16 0.0052
108 TOXIC EPIDERMAL NECROLYSIS 78 0.0051
109 TENDON INJURY 19 0.0051
110 PERIODONTITIS 11 0.0051
111 CUTANEOUS VASCULITIS 18 0.0049
112 PHOTOPHOBIA 91 0.0048
113 NECROTISING COLITIS 6 0.0047
114 DACRYOSTENOSIS ACQUIRED 6 0.0046
115 ASTIGMATISM 7 0.0046
116 HENOCH-SCHONLEIN PURPURA 10 0.0046
117 MULTIPLE-DRUG RESISTANCE 14 0.0045
118 SWELLING OF EYELID 28 0.0045
119 EAR HAEMORRHAGE 9 0.0044
120 OTOTOXICITY 8 0.0043
121 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 10 0.0043
122 EPIDIDYMITIS 5 0.0043
123 HYPERACUSIS 16 0.0043
124 MUSCLE CONTRACTIONS INVOLUNTARY 15 0.0043
125 INTRUSIVE THOUGHTS 5 0.0042
126 IRIDOCYCLITIS 13 0.0041
127 BICYTOPENIA 8 0.0041
128 HYPERAEMIA 8 0.0041
129 TENDON RUPTURE 50 0.0040
130 HALLUCINATIONS, MIXED 17 0.0040
131 PERSECUTORY DELUSION 10 0.0040
132 TENOSYNOVITIS 11 0.0040
133 EYE INFECTION 44 0.0039
134 HEPATOSPLENOMEGALY 10 0.0039
135 EYELID MARGIN CRUSTING 11 0.0038
136 CARDIOACTIVE DRUG LEVEL INCREASED 5 0.0038
137 PUSTULE 9 0.0038
138 WEIGHT BEARING DIFFICULTY 10 0.0037
139 RENAL TUBULAR ACIDOSIS 8 0.0037
140 OCULAR HYPERTENSION 7 0.0036
141 PSEUDOMEMBRANOUS COLITIS 8 0.0036
142 PYELONEPHRITIS ACUTE 7 0.0036
143 TOXIC SKIN ERUPTION 35 0.0035
144 EYE OPERATION 16 0.0035
145 PYELONEPHRITIS 30 0.0035
146 PRODUCT PACKAGING DIFFICULT TO OPEN 9 0.0034
147 INTRAOCULAR PRESSURE INCREASED 44 0.0034
148 MACULAR OEDEMA 19 0.0034
149 GENITAL PAIN 5 0.0034
150 CONJUNCTIVITIS ALLERGIC 5 0.0034
151 EYE DISCHARGE 35 0.0034
152 CONJUNCTIVAL HYPERAEMIA 12 0.0034
153 LIVER TRANSPLANT REJECTION 6 0.0033
154 MUSCLE RUPTURE 13 0.0033
155 VITREOUS FLOATERS 32 0.0033
156 CARTILAGE INJURY 8 0.0032
157 BLEPHARITIS 13 0.0032
158 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 25 0.0032
159 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 16 0.0032
160 DERMATITIS EXFOLIATIVE 16 0.0032
161 CEREBELLAR SYNDROME 7 0.0032
162 RETINAL OEDEMA 6 0.0031
163 ECCHYMOSIS 21 0.0031
164 HEPATIC CYTOLYSIS 39 0.0031
165 JOINT NOISE 6 0.0031
166 NECROSIS 17 0.0031
167 PURPURA 27 0.0030
168 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 6 0.0030
169 EYELID DISORDER 7 0.0030
170 FOOD INTOLERANCE 11 0.0030
171 ENTEROBACTER INFECTION 5 0.0030
172 CHOLESTASIS 57 0.0030
173 END STAGE RENAL DISEASE 53 0.0029
174 EYE IRRITATION 166 0.0029
175 CONJUNCTIVAL HAEMORRHAGE 11 0.0029
176 ELECTRIC SHOCK SENSATION 8 0.0029
177 ESCHERICHIA SEPSIS 8 0.0028
178 LACRIMATION INCREASED 83 0.0027
179 ESSENTIAL HYPERTENSION 5 0.0027
180 RETINAL DISORDER 7 0.0027
181 AGRANULOCYTOSIS 50 0.0027
182 MENINGITIS ASEPTIC 12 0.0027
183 HYPOPROTEINAEMIA 5 0.0026
184 NEURALGIA 64 0.0026
185 HYPOREFLEXIA 5 0.0026
186 MUSCLE ATROPHY 33 0.0026
187 BILIRUBIN CONJUGATED INCREASED 6 0.0026
188 TYPE I HYPERSENSITIVITY 9 0.0026
189 PATHOGEN RESISTANCE 23 0.0025
190 IMMOBILE 11 0.0025
191 CHRONIC KIDNEY DISEASE 190 0.0025
192 DERMATITIS BULLOUS 18 0.0025
193 SKIN EROSION 8 0.0025
194 CONJUNCTIVITIS 46 0.0025
195 HAEMOLYTIC ANAEMIA 22 0.0025
196 SKIN HYPERPIGMENTATION 21 0.0024
197 RETINAL TEAR 6 0.0024
198 VASCULAR DEVICE INFECTION 11 0.0024
199 OTITIS MEDIA 8 0.0024
200 AORTIC DISSECTION 10 0.0024
201 ERYTHEMA OF EYELID 13 0.0024
202 NEGATIVE THOUGHTS 7 0.0024
203 STRABISMUS 7 0.0024
204 SLEEP TERROR 10 0.0024
205 DRUG RESISTANCE 61 0.0024
206 EXCORIATION 6 0.0024
207 HYPERTHERMIA 18 0.0024
208 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 12 0.0024
209 RASH MACULO-PAPULAR 52 0.0023
210 HORDEOLUM 10 0.0023
211 PERIORBITAL SWELLING 13 0.0023
212 OCULAR HYPERAEMIA 109 0.0023
213 EYE SWELLING 84 0.0023
214 STEVENS-JOHNSON SYNDROME 50 0.0022
215 AREFLEXIA 6 0.0022
216 HAEMORRHAGIC DIATHESIS 8 0.0022
217 RETINAL HAEMORRHAGE 16 0.0022
218 EOSINOPHILIA 39 0.0022
219 FEAR OF DEATH 5 0.0022
220 PANIC REACTION 16 0.0022
221 HEPATITIS ACUTE 14 0.0022
222 INTERNATIONAL NORMALISED RATIO INCREASED 61 0.0021
223 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 55 0.0021
224 DEAFNESS NEUROSENSORY 7 0.0021
225 BLINDNESS UNILATERAL 30 0.0021
226 HEPATOCELLULAR INJURY 30 0.0021
227 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 8 0.0021
228 EPSTEIN-BARR VIRUS INFECTION 13 0.0021
229 ENCEPHALOPATHY 51 0.0021
230 PHOTOPSIA 13 0.0021
231 EAR INFECTION 54 0.0020
232 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 5 0.0020
233 WRONG DRUG ADMINISTERED 18 0.0020
234 PATENT DUCTUS ARTERIOSUS 8 0.0020
235 OESOPHAGEAL CANDIDIASIS 8 0.0020
236 HEPATITIS CHOLESTATIC 12 0.0020
237 HAEMORRHAGE SUBCUTANEOUS 7 0.0020
238 DISSEMINATED TUBERCULOSIS 5 0.0019
239 LOCALISED OEDEMA 9 0.0019
240 CATARACT 114 0.0019
241 ABNORMAL LOSS OF WEIGHT 13 0.0019
242 HYPERSENSITIVITY VASCULITIS 5 0.0019
243 INFUSION SITE PRURITUS 6 0.0019
244 VISUAL ACUITY REDUCED 63 0.0019
245 BLADDER PAIN 6 0.0019
246 PULMONARY TUBERCULOSIS 8 0.0019
247 CATARACT OPERATION 11 0.0019
248 ASPHYXIA 15 0.0018
249 PRODUCT ADMINISTRATION ERROR 37 0.0018
250 TONGUE DISCOLOURATION 8 0.0018
251 CLONUS 5 0.0018
252 ANHEDONIA 48 0.0018
253 ORAL CANDIDIASIS 24 0.0018
254 TUBULOINTERSTITIAL NEPHRITIS 34 0.0018
255 INTRACRANIAL PRESSURE INCREASED 10 0.0018
256 POST-TRAUMATIC STRESS DISORDER 12 0.0018
257 PLANTAR FASCIITIS 6 0.0018
258 TINNITUS 80 0.0017
259 HERPES VIRUS INFECTION 10 0.0017
260 HYPERREFLEXIA 6 0.0017
261 ESCHERICHIA INFECTION 14 0.0017
262 HISTIOCYTOSIS HAEMATOPHAGIC 5 0.0017
263 FACIAL PAIN 15 0.0017
264 ATYPICAL PNEUMONIA 5 0.0017
265 GAMMA-GLUTAMYLTRANSFERASE INCREASED 37 0.0017
266 EAR DISCOMFORT 17 0.0017
267 FEBRILE BONE MARROW APLASIA 7 0.0016
268 ESCHERICHIA URINARY TRACT INFECTION 7 0.0016
269 JAW DISORDER 9 0.0016
270 HEPATITIS 42 0.0016
271 RETINAL DETACHMENT 15 0.0016
272 PARADOXICAL DRUG REACTION 6 0.0016
273 ABNORMAL SENSATION IN EYE 7 0.0016
274 CHRONIC SINUSITIS 6 0.0016
275 ACUTE KIDNEY INJURY 243 0.0016
276 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
277 CARDIAC VALVE DISEASE 9 0.0016
278 MYOSITIS 14 0.0016
279 LYMPHOPENIA 22 0.0016
280 RENAL FAILURE 206 0.0015
281 EAR PAIN 30 0.0015
282 SKIN NECROSIS 8 0.0015
283 FACE OEDEMA 26 0.0015
284 HYPERTRIGLYCERIDAEMIA 9 0.0015
285 INFUSION SITE HAEMORRHAGE 5 0.0015
286 PRODUCT DELIVERY MECHANISM ISSUE 8 0.0015
287 BK VIRUS INFECTION 5 0.0015
288 SKIN ABRASION 7 0.0015
289 SHOCK HAEMORRHAGIC 12 0.0015
290 HYDROCEPHALUS 8 0.0015
291 EYELID OEDEMA 17 0.0015
292 ARTHRITIS BACTERIAL 6 0.0015
293 HYPERURICAEMIA 6 0.0015
294 HEPATIC FIBROSIS 5 0.0015
295 ASTHENOPIA 8 0.0015
296 ENCEPHALITIS 10 0.0014
297 FORMICATION 10 0.0014
298 MYOCLONUS 17 0.0014
299 CLOSTRIDIUM DIFFICILE COLITIS 15 0.0014
300 HYPOTONIA 14 0.0014
301 GLAUCOMA 27 0.0014
302 NEUROLOGICAL SYMPTOM 8 0.0014
303 HERPES SIMPLEX 9 0.0014
304 OCULAR ICTERUS 6 0.0014
305 TRANSPLANT REJECTION 11 0.0014
306 ASPERGILLUS INFECTION 9 0.0014
307 PARONYCHIA 6 0.0014
308 RHINITIS 11 0.0014
309 HAEMATOMA 35 0.0013
310 SKIN MASS 9 0.0013
311 PLEURISY 8 0.0013
312 RENAL FAILURE ACUTE 57 0.0013
313 PETECHIAE 14 0.0013
314 POLYNEUROPATHY 16 0.0013
315 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 10 0.0013
316 MULTI-ORGAN FAILURE 23 0.0013
317 MUSCLE TWITCHING 30 0.0013
318 PIGMENTATION DISORDER 8 0.0013
319 HYPERKERATOSIS 7 0.0013
320 DRY EYE 63 0.0013
321 RECALLED PRODUCT ADMINISTERED 12 0.0013
322 ECONOMIC PROBLEM 19 0.0013
323 KIDNEY TRANSPLANT REJECTION 6 0.0012
324 PRODUCT LEAKAGE 7 0.0012
325 CANDIDA INFECTION 21 0.0012
326 PANIC ATTACK 45 0.0012
327 GASTROENTERITIS 18 0.0012
328 HEPATOMEGALY 12 0.0012
329 MUSCULOSKELETAL DISCOMFORT 21 0.0012
330 TOXIC ENCEPHALOPATHY 6 0.0012
331 STAPHYLOCOCCAL INFECTION 39 0.0012
332 BACTERAEMIA 14 0.0012
333 PETIT MAL EPILEPSY 6 0.0012
334 CACHEXIA 6 0.0012
335 MALNUTRITION 13 0.0012
336 ANURIA 10 0.0012
337 MULTIPLE ALLERGIES 9 0.0011
338 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
339 EXTRASYSTOLES 8 0.0011
340 PARTIAL SEIZURES 6 0.0011
341 DIVERTICULUM INTESTINAL 5 0.0011
342 PAPULE 8 0.0011
343 HALLUCINATION, AUDITORY 18 0.0011
344 GENERALISED OEDEMA 14 0.0011
345 BLINDNESS 46 0.0011
346 DRUG ERUPTION 20 0.0011
347 SEPTIC SHOCK 49 0.0011
348 EYE HAEMORRHAGE 15 0.0011
349 VISION BLURRED 153 0.0011
350 MUSCLE DISORDER 9 0.0011
351 VISUAL FIELD DEFECT 8 0.0011
352 ACUTE HEPATIC FAILURE 15 0.0011
353 MEDICATION ERROR 61 0.0011
354 IMMUNE THROMBOCYTOPENIA 5 0.0011
355 EAR DISORDER 5 0.0011
356 VISUAL IMPAIRMENT 135 0.0011
357 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
358 BLINDNESS TRANSIENT 8 0.0011
359 NERVE INJURY 12 0.0011
360 STREPTOCOCCAL INFECTION 6 0.0011
361 IMPAIRED WORK ABILITY 23 0.0011
362 ORAL HERPES 21 0.0011
363 ATRIAL SEPTAL DEFECT 9 0.0011
364 ACUTE PULMONARY OEDEMA 6 0.0011
365 STATUS EPILEPTICUS 12 0.0011
366 PAROSMIA 8 0.0011
367 BLOOD URINE PRESENT 20 0.0011
368 LIPASE INCREASED 8 0.0010
369 HYPOVOLAEMIC SHOCK 5 0.0010
370 ENTEROCOLITIS 6 0.0010
371 PANCYTOPENIA 58 0.0010
372 SOCIAL AVOIDANT BEHAVIOUR 6 0.0010
373 TRANSAMINASES INCREASED 23 0.0010
374 HYPOALBUMINAEMIA 8 0.0010
375 APATHY 15 0.0010
376 GROIN PAIN 9 0.0010
377 TUMOUR LYSIS SYNDROME 9 0.0010
378 NEUROPATHY PERIPHERAL 97 0.0010
379 NASAL DISCOMFORT 8 0.0010
380 BLOOD ALKALINE PHOSPHATASE INCREASED 25 0.0010
381 SLEEP APNOEA SYNDROME 19 0.0010
382 HAEMATURIA 34 0.0010
383 OPTIC NEURITIS 9 0.0010
384 SEASONAL ALLERGY 14 0.0010
385 ADRENAL INSUFFICIENCY 12 0.0010
386 DIVERTICULUM 7 0.0010
387 RASH PAPULAR 22 0.0010
388 MUSCLE INJURY 8 0.0010
389 DERMATITIS CONTACT 11 0.0010
390 CLOSTRIDIUM DIFFICILE INFECTION 21 0.0010
391 NERVOUS SYSTEM DISORDER 30 0.0010
392 UVEITIS 13 0.0010
393 INFUSION SITE SWELLING 6 0.0010
394 SKIN LESION 26 0.0009
395 ARTHROPOD BITE 7 0.0009
396 DRUG INTERACTION 149 0.0009
397 PRODUCT CONTAINER ISSUE 8 0.0009
398 PSEUDOMONAS INFECTION 8 0.0009
399 INFUSION SITE PAIN 12 0.0009
400 CHEILITIS 5 0.0009
401 VITAMIN D DEFICIENCY 9 0.0009
402 EYE PRURITUS 31 0.0009
403 DRUG DISPENSING ERROR 14 0.0009
404 HYPOGAMMAGLOBULINAEMIA 6 0.0009
405 PHOTOSENSITIVITY REACTION 15 0.0009
406 DEAFNESS UNILATERAL 5 0.0009
407 FIBROMYALGIA 22 0.0009
408 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 8 0.0009
409 THROMBOCYTOPENIA 101 0.0009
410 HALLUCINATION, VISUAL 19 0.0009
411 SALIVARY HYPERSECRETION 9 0.0009
412 BRAIN FOG 14 0.0009
413 PANCREATITIS ACUTE 20 0.0009
414 OSTEONECROSIS OF JAW 22 0.0009
415 PRODUCT USE COMPLAINT 14 0.0009
416 EYELID PTOSIS 9 0.0009
417 GENERAL PHYSICAL CONDITION ABNORMAL 6 0.0009
418 BLOOD ALBUMIN DECREASED 7 0.0009
419 EYE DISORDER 29 0.0009
420 DRUG TOXICITY 12 0.0009
421 RIB FRACTURE 18 0.0009
422 HYPERBILIRUBINAEMIA 9 0.0009
423 EXERCISE TOLERANCE DECREASED 5 0.0009
424 HYPERTRANSAMINASAEMIA 6 0.0009
425 POST PROCEDURAL INFECTION 7 0.0009
426 NEPHROPATHY 8 0.0009
427 JAUNDICE 23 0.0009
428 DRUG LEVEL INCREASED 14 0.0008
429 LEUKOPENIA 42 0.0008
430 GRAFT VERSUS HOST DISEASE 6 0.0008
431 RESPIRATORY DISTRESS 23 0.0008
432 CYANOSIS 13 0.0008
433 RASH PUSTULAR 6 0.0008
434 IMPAIRED HEALING 27 0.0008
435 INGUINAL HERNIA 5 0.0008
436 MYALGIA 139 0.0008
437 RENAL TUBULAR NECROSIS 8 0.0008
438 SPINAL OSTEOARTHRITIS 7 0.0008
439 JOINT INJURY 17 0.0008
440 EMPHYSEMA 8 0.0008
441 LYMPHADENOPATHY 28 0.0008
442 ACIDOSIS 6 0.0008
443 BURNING SENSATION 55 0.0008
444 DISSEMINATED INTRAVASCULAR COAGULATION 11 0.0008
445 GASTROINTESTINAL INFECTION 7 0.0008
446 MYDRIASIS 10 0.0008
447 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
448 ANAL INCONTINENCE 7 0.0008
449 THROAT TIGHTNESS 21 0.0008
450 MADAROSIS 9 0.0008
451 DIALYSIS 11 0.0008
452 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
453 DELUSION 12 0.0008
454 NECK PAIN 43 0.0008
455 CONFUSIONAL STATE 123 0.0008
456 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
457 ANAEMIA 145 0.0008
458 ORAL PAIN 17 0.0008
459 GRAND MAL CONVULSION 7 0.0008
460 INCONTINENCE 8 0.0008
461 RENAL CYST 6 0.0008
462 VERTIGO 46 0.0008
463 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
464 ELECTROCARDIOGRAM QT PROLONGED 27 0.0007
465 HEPATIC ENCEPHALOPATHY 7 0.0007
466 PARAESTHESIA 118 0.0007
467 URINARY INCONTINENCE 22 0.0007
468 PULMONARY MASS 11 0.0007
469 DECUBITUS ULCER 6 0.0007
470 ALANINE AMINOTRANSFERASE INCREASED 45 0.0007
471 DIPLOPIA 19 0.0007
472 MUSCULAR WEAKNESS 83 0.0007
473 HYPERCHOLESTEROLAEMIA 7 0.0007
474 OSTEOPENIA 11 0.0007
475 DENTAL CARIES 8 0.0007
476 CYTOMEGALOVIRUS INFECTION 12 0.0007
477 SECRETION DISCHARGE 9 0.0007
478 PHARYNGEAL SWELLING 7 0.0007
479 RASH MACULAR 25 0.0007
480 SKIN INFECTION 8 0.0007
481 HYPERKALAEMIA 25 0.0007
482 SENSATION OF FOREIGN BODY 6 0.0007
483 LUNG INFECTION 11 0.0007
484 ANXIETY 201 0.0007
485 NEUTROPENIA 96 0.0007
486 SINUS TACHYCARDIA 10 0.0007
487 SCAB 8 0.0007
488 DRUG-INDUCED LIVER INJURY 22 0.0007
489 ANGIOEDEMA 31 0.0007
490 ANAPHYLACTIC SHOCK 18 0.0007
491 INFLAMMATION 36 0.0007
492 BLOOD MAGNESIUM DECREASED 6 0.0007
493 MUSCLE STRAIN 6 0.0007
494 CARDIO-RESPIRATORY ARREST 29 0.0007
495 PARAESTHESIA ORAL 10 0.0007
496 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
497 MUSCULOSKELETAL DISORDER 13 0.0007
498 PULMONARY CONGESTION 9 0.0007
499 ASPARTATE AMINOTRANSFERASE INCREASED 36 0.0007
500 PAIN IN JAW 19 0.0007
501 HYPERLIPIDAEMIA 8 0.0007
502 MANIA 11 0.0007
503 URINARY TRACT INFECTION 114 0.0007
504 PALPITATIONS 78 0.0007
505 RENAL PAIN 7 0.0007
506 FUNGAL INFECTION 22 0.0007
507 BURSITIS 8 0.0007
508 AORTIC ANEURYSM 5 0.0007
509 PNEUMONIA BACTERIAL 6 0.0007
510 LUNG DISORDER 32 0.0007
511 DEAFNESS 17 0.0006
512 HEPATIC STEATOSIS 12 0.0006
513 THERAPY INTERRUPTED 46 0.0006
514 EJECTION FRACTION DECREASED 10 0.0006
515 DIARRHOEA HAEMORRHAGIC 6 0.0006
516 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
517 THERAPY PARTIAL RESPONDER 10 0.0006
518 AGITATION 47 0.0006
519 BONE MARROW FAILURE 13 0.0006
520 OSTEOARTHRITIS 27 0.0006
521 BLOOD BILIRUBIN INCREASED 17 0.0006
522 DEVICE USE ISSUE 11 0.0006
523 IMPAIRED QUALITY OF LIFE 9 0.0006
524 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 30 0.0006
525 SENSORY DISTURBANCE 10 0.0006
526 ANOSMIA 9 0.0006
527 BRONCHITIS 46 0.0006
528 DIABETES MELLITUS INADEQUATE CONTROL 11 0.0006
529 GENERAL PHYSICAL HEALTH DETERIORATION 71 0.0006
530 PLATELET COUNT INCREASED 8 0.0006
531 DISTURBANCE IN ATTENTION 33 0.0006
532 HALLUCINATION 46 0.0006
533 HICCUPS 5 0.0006
534 BEDRIDDEN 8 0.0006
535 GASTRITIS 16 0.0006
536 TACHYCARDIA 54 0.0006
537 COLITIS 23 0.0006
538 UPPER RESPIRATORY TRACT INFECTION 28 0.0006
539 DISORIENTATION 24 0.0006
540 ELECTROLYTE IMBALANCE 7 0.0006
541 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 33 0.0006
542 ARTHRALGIA 248 0.0006
543 APHASIA 18 0.0006
544 FULL BLOOD COUNT DECREASED 12 0.0006
545 SLEEP DISORDER 42 0.0006
546 INFUSION SITE ERYTHEMA 5 0.0006
547 HYPOTHERMIA 6 0.0006
548 PYREXIA 205 0.0006
549 HIP FRACTURE 19 0.0006
550 IMPAIRED GASTRIC EMPTYING 8 0.0006
551 MACULAR DEGENERATION 7 0.0006
552 RASH ERYTHEMATOUS 28 0.0006
553 SINUSITIS 60 0.0006
554 MUSCLE RIGIDITY 7 0.0006
555 INITIAL INSOMNIA 6 0.0006
556 DEVICE RELATED INFECTION 9 0.0006
557 TEMPERATURE INTOLERANCE 6 0.0006
558 GASTROINTESTINAL DISORDER 52 0.0006
559 POOR VENOUS ACCESS 6 0.0006
560 GASTRIC ULCER 11 0.0006
561 NOCTURIA 7 0.0006
562 COORDINATION ABNORMAL 8 0.0006
563 ACUTE RESPIRATORY FAILURE 11 0.0006
564 CYTOPENIA 7 0.0006
565 NEUROTOXICITY 10 0.0006
566 CONDITION AGGRAVATED 173 0.0006
567 DEPRESSED MOOD 30 0.0006
568 IMMUNOSUPPRESSION 5 0.0006
569 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
570 MULTIPLE ORGAN DYSFUNCTION SYNDROME 16 0.0006
571 HEAD DISCOMFORT 10 0.0006
572 SCIATICA 9 0.0006
573 PHARYNGITIS 7 0.0006
574 GASTROOESOPHAGEAL REFLUX DISEASE 45 0.0006
575 PARALYSIS 8 0.0006
576 DERMATITIS ALLERGIC 7 0.0006
577 MUSCLE TIGHTNESS 9 0.0006
578 MYELODYSPLASTIC SYNDROME 8 0.0006
579 SKIN LACERATION 6 0.0006
580 PALLOR 15 0.0006
581 PNEUMONITIS 15 0.0006
582 DYSPHAGIA 52 0.0005
583 DELIRIUM 19 0.0005
584 INFECTION 79 0.0005
585 GASTROINTESTINAL PAIN 6 0.0005
586 ROTATOR CUFF SYNDROME 7 0.0005
587 ANOREXIA 7 0.0005
588 SKIN ULCER 14 0.0005
589 FOOT DEFORMITY 6 0.0005
590 HYPOAESTHESIA 81 0.0005
591 DEPRESSION 123 0.0005
592 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
593 ARTHROPATHY 30 0.0005
594 RENAL INJURY 16 0.0005
595 SEPSIS 60 0.0005
596 DEMENTIA 15 0.0005
597 NODULE 7 0.0005
598 ERYTHEMA MULTIFORME 5 0.0005
599 ARTHRITIS 42 0.0005
600 FLANK PAIN 5 0.0005
601 INSOMNIA 141 0.0005
602 MENTAL DISORDER 23 0.0005
603 CONTRAINDICATED PRODUCT ADMINISTERED 16 0.0005
604 ARRHYTHMIA 25 0.0005
605 PROTEINURIA 10 0.0005
606 MUSCULOSKELETAL STIFFNESS 46 0.0005
607 CONVULSION 30 0.0005
608 RENAL IMPAIRMENT 44 0.0005
609 ANGINA PECTORIS 15 0.0005
610 EPILEPSY 16 0.0005
611 CARDIAC FAILURE 42 0.0005
612 C-REACTIVE PROTEIN INCREASED 19 0.0005
613 SHOCK 12 0.0005
614 AGEUSIA 13 0.0005
615 FEAR 14 0.0005
616 TREATMENT FAILURE 43 0.0005
617 MUSCULOSKELETAL CHEST PAIN 8 0.0005
618 HYPONATRAEMIA 29 0.0005
619 BONE DENSITY DECREASED 16 0.0005
620 HEPATIC FUNCTION ABNORMAL 19 0.0005
621 PRODUCT DOSE OMISSION ISSUE 149 0.0005
622 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
623 COMA 24 0.0005
624 EMOTIONAL DISTRESS 61 0.0005
625 CHOLECYSTITIS 6 0.0005
626 MASS 7 0.0005
627 CARPAL TUNNEL SYNDROME 7 0.0005
628 HYPOKALAEMIA 23 0.0005
629 OSTEOMYELITIS 9 0.0005
630 SKIN REACTION 7 0.0005
631 RHINORRHOEA 32 0.0005
632 LACTIC ACIDOSIS 16 0.0005
633 HEPATOTOXICITY 11 0.0005
634 RENAL DISORDER 23 0.0005
635 COGNITIVE DISORDER 23 0.0005
636 DRUG LEVEL DECREASED 5 0.0005
637 BRONCHOSPASM 7 0.0005
638 THERAPY NON-RESPONDER 22 0.0005
639 OSTEOPOROSIS 20 0.0005
640 HYPERCALCAEMIA 6 0.0005
641 PAIN IN EXTREMITY 143 0.0005
642 VIRAL INFECTION 16 0.0005
643 DEPRESSED LEVEL OF CONSCIOUSNESS 19 0.0005
644 GAIT INABILITY 16 0.0005
645 LIMB INJURY 13 0.0005
646 DERMATITIS 10 0.0005
647 SPEECH DISORDER 25 0.0005
648 PLEURAL EFFUSION 29 0.0005
649 PERICARDIAL EFFUSION 11 0.0005
650 TREATMENT NONCOMPLIANCE 26 0.0005
651 MOUTH ULCERATION 10 0.0005
652 SKIN HAEMORRHAGE 7 0.0005
653 HERPES ZOSTER 27 0.0005
654 SUICIDAL IDEATION 43 0.0005
655 BACK PAIN 109 0.0005
656 BODY HEIGHT DECREASED 5 0.0005
657 PARANOIA 8 0.0005
658 THERAPEUTIC RESPONSE DECREASED 28 0.0005
659 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
660 HAEMORRHOIDS 9 0.0005
661 SURGERY 27 0.0005
662 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
663 INTENTIONAL DOSE OMISSION 13 0.0005
664 RHABDOMYOLYSIS 19 0.0005
665 DISABILITY 9 0.0005
666 EPISTAXIS 34 0.0005
667 SINUS DISORDER 9 0.0005
668 ANAPHYLACTIC REACTION 25 0.0005
669 LIMB DISCOMFORT 14 0.0005
670 PRESYNCOPE 11 0.0005
671 TOOTH DISORDER 10 0.0004
672 ACUTE MYELOID LEUKAEMIA 7 0.0004
673 ISCHAEMIC STROKE 8 0.0004
674 SWOLLEN TONGUE 14 0.0004
675 LIVER INJURY 11 0.0004
676 DYSSTASIA 13 0.0004
677 BLISTER 25 0.0004
678 BLOOD CREATININE INCREASED 29 0.0004
679 SINUS CONGESTION 6 0.0004
680 EXTRAPYRAMIDAL DISORDER 11 0.0004
681 OEDEMA 24 0.0004
682 MUSCLE SPASMS 81 0.0004
683 PRODUCTIVE COUGH 21 0.0004
684 CYSTITIS 14 0.0004
685 BONE DISORDER 8 0.0004
686 ABSCESS 7 0.0004
687 HEADACHE 275 0.0004
688 HYPOTHYROIDISM 14 0.0004
689 NEPHROLITHIASIS 20 0.0004
690 DYSURIA 16 0.0004
691 INTERSTITIAL LUNG DISEASE 21 0.0004
692 ERYTHEMA 89 0.0004
693 HEPATIC FAILURE 13 0.0004
694 TREMOR 71 0.0004
695 OXYGEN SATURATION DECREASED 24 0.0004
696 INTESTINAL OBSTRUCTION 16 0.0004
697 FOOT FRACTURE 8 0.0004
698 BLOOD IRON DECREASED 5 0.0004
699 ATAXIA 5 0.0004
700 FEMUR FRACTURE 13 0.0004
701 BLOOD UREA INCREASED 7 0.0004
702 DYSGEUSIA 31 0.0004
703 LOWER LIMB FRACTURE 8 0.0004
704 SWELLING FACE 27 0.0004
705 HYPOKINESIA 6 0.0004
706 FLUID RETENTION 21 0.0004
707 HYPOGLYCAEMIA 20 0.0004
708 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
709 URTICARIA 69 0.0004
710 PNEUMONIA 133 0.0004
711 PAIN 252 0.0004
712 OEDEMA PERIPHERAL 50 0.0004
713 RESTLESSNESS 15 0.0004
714 BONE PAIN 24 0.0004
715 MELAENA 9 0.0004
716 SCAR 7 0.0004
717 ILLNESS 42 0.0004
718 MEMORY IMPAIRMENT 56 0.0004
719 GAIT DISTURBANCE 78 0.0004
720 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
721 CARDIOMYOPATHY 6 0.0004
722 NIGHTMARE 14 0.0004
723 PULMONARY OEDEMA 18 0.0004
724 ECZEMA 21 0.0004
725 RESPIRATORY DISORDER 12 0.0004
726 MUSCULOSKELETAL PAIN 21 0.0004
727 ATRIAL FIBRILLATION 39 0.0004
728 PNEUMONIA ASPIRATION 10 0.0004
729 ABDOMINAL PAIN 93 0.0004
730 CYTOKINE RELEASE SYNDROME 8 0.0004
731 DYSARTHRIA 15 0.0004
732 PRODUCT DOSE OMISSION 26 0.0004
733 SEIZURE 46 0.0004
734 HYPOXIA 14 0.0004
735 MENTAL STATUS CHANGES 11 0.0004
736 HYPOACUSIS 17 0.0004
737 BALANCE DISORDER 34 0.0004
738 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
739 FALL 130 0.0004
740 SKIN DISORDER 13 0.0004
741 RASH PRURITIC 21 0.0004
742 TOOTHACHE 7 0.0004
743 HIATUS HERNIA 5 0.0004
744 INFLUENZA 43 0.0004
745 RESPIRATORY TRACT INFECTION 10 0.0004
746 ACCIDENTAL OVERDOSE 14 0.0004
747 IMMUNE SYSTEM DISORDER 5 0.0004
748 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
749 PRODUCT PRESCRIBING ERROR 9 0.0004
750 BRADYCARDIA 20 0.0004
751 OBESITY 6 0.0004
752 EATING DISORDER 8 0.0004
753 METABOLIC ACIDOSIS 12 0.0004
754 PRURITUS 144 0.0004
755 RASH 163 0.0004
756 NIGHT SWEATS 12 0.0004
757 HYPERSENSITIVITY 69 0.0004
758 DYSPNOEA EXERTIONAL 14 0.0004
759 PSORIATIC ARTHROPATHY 15 0.0004
760 BLOOD POTASSIUM INCREASED 6 0.0004
761 DYSKINESIA 15 0.0004
762 PRODUCT DISPENSING ERROR 8 0.0004
763 OROPHARYNGEAL PAIN 34 0.0004
764 CHILLS 43 0.0004
765 CHOLELITHIASIS 12 0.0004
766 BLOOD POTASSIUM DECREASED 11 0.0004
767 DIARRHOEA 235 0.0004
768 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
769 CARDIAC ARREST 30 0.0004
770 VENTRICULAR TACHYCARDIA 6 0.0004
771 FEBRILE NEUTROPENIA 24 0.0004
772 DIVERTICULITIS 10 0.0004
773 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
774 NO ADVERSE EVENT 65 0.0004
775 SNEEZING 8 0.0004
776 RESPIRATORY FAILURE 26 0.0004
777 HYPERTENSION 75 0.0004
778 ABNORMAL BEHAVIOUR 14 0.0004
779 BLOOD PRESSURE ABNORMAL 7 0.0004
780 HYPOPHAGIA 9 0.0004
781 DYSPNOEA 198 0.0003
782 OFF LABEL USE 306 0.0003
783 CARDIOGENIC SHOCK 5 0.0003
784 ASTHENIA 131 0.0003
785 RASH GENERALISED 9 0.0003
786 WEIGHT DECREASED 97 0.0003
787 GASTROINTESTINAL HAEMORRHAGE 29 0.0003
788 STOMATITIS 21 0.0003
789 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 70 0.0003
790 HYPERTHYROIDISM 5 0.0003
791 ADVERSE DRUG REACTION 31 0.0003
792 FEEDING DISORDER 7 0.0003
793 ORTHOSTATIC HYPOTENSION 6 0.0003
794 BODY TEMPERATURE INCREASED 7 0.0003
795 HEART RATE DECREASED 12 0.0003
796 WHITE BLOOD CELL COUNT DECREASED 37 0.0003
797 COLD SWEAT 6 0.0003
798 ASCITES 10 0.0003
799 PSYCHOTIC DISORDER 10 0.0003
800 PERITONITIS 7 0.0003
801 PERIPHERAL SWELLING 52 0.0003
802 DISEASE RECURRENCE 16 0.0003
803 THIRST 6 0.0003
804 COLON CANCER 5 0.0003
805 DEVICE ISSUE 30 0.0003
806 HEART RATE INCREASED 33 0.0003
807 GASTROENTERITIS VIRAL 6 0.0003
808 CHEST DISCOMFORT 34 0.0003
809 HYPOAESTHESIA ORAL 5 0.0003
810 COUGH 93 0.0003
811 SWELLING 31 0.0003
812 INTENTIONAL PRODUCT USE ISSUE 29 0.0003
813 NASOPHARYNGITIS 61 0.0003
814 PELVIC PAIN 6 0.0003
815 DEHYDRATION 44 0.0003
816 CHEST PAIN 61 0.0003
817 TRANSIENT ISCHAEMIC ATTACK 11 0.0003
818 COVID-19 57 0.0003
819 DYSPHONIA 19 0.0003
820 PRURITUS GENERALISED 7 0.0003
821 PRODUCT PRESCRIBING ISSUE 7 0.0003
822 FATIGUE 250 0.0003
823 WHEEZING 19 0.0003
824 MOBILITY DECREASED 23 0.0003
825 PLATELET COUNT DECREASED 34 0.0003
826 BLOOD SODIUM DECREASED 6 0.0003
827 HYPOCALCAEMIA 6 0.0003
828 VOMITING 148 0.0003
829 LETHARGY 18 0.0003
830 POST PROCEDURAL COMPLICATION 6 0.0003
831 MALAISE 137 0.0003
832 HAEMOGLOBIN DECREASED 32 0.0003
833 NAUSEA 246 0.0003
834 PRODUCT USE IN UNAPPROVED INDICATION 77 0.0003
835 ERUCTATION 6 0.0003
836 CHROMATURIA 7 0.0003
837 EXPOSURE VIA SKIN CONTACT 8 0.0003
838 HEPATIC ENZYME INCREASED 21 0.0003
839 INCORRECT ROUTE OF DRUG ADMINISTRATION 11 0.0003
840 CEREBRAL HAEMORRHAGE 11 0.0003
841 CONSTIPATION 67 0.0003
842 MUCOSAL INFLAMMATION 8 0.0003
843 DERMATITIS ATOPIC 16 0.0003
844 PANCREATITIS 16 0.0003
845 HYPERGLYCAEMIA 11 0.0003
846 BLOOD PRESSURE DECREASED 20 0.0003
847 PRESCRIBED UNDERDOSE 6 0.0003
848 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
849 INJURY 21 0.0003
850 CELLULITIS 15 0.0003
851 NEUTROPHIL COUNT DECREASED 12 0.0003
852 FEELING HOT 18 0.0003
853 MOOD ALTERED 8 0.0003
854 DECREASED APPETITE 68 0.0003
855 PRODUCT USE ISSUE 55 0.0003
856 PRODUCT PREPARATION ERROR 6 0.0003
857 CONTUSION 28 0.0003
858 JOINT SWELLING 35 0.0003
859 THROAT IRRITATION 13 0.0003
860 ABNORMAL DREAMS 8 0.0003
861 TOOTH LOSS 6 0.0003
862 NASAL CONGESTION 17 0.0003
863 HYPOTENSION 58 0.0003
864 POLLAKIURIA 12 0.0003
865 HAEMOPTYSIS 8 0.0003
866 INTENTIONAL PRODUCT MISUSE 25 0.0003
867 FEELING ABNORMAL 68 0.0003
868 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
869 SKIN DISCOLOURATION 13 0.0003
870 DIZZINESS 140 0.0003
871 DISCOMFORT 17 0.0003
872 DEEP VEIN THROMBOSIS 18 0.0003
873 ABDOMINAL PAIN LOWER 7 0.0003
874 FAECES DISCOLOURED 6 0.0003
875 HAEMATEMESIS 7 0.0003
876 LIVER FUNCTION TEST ABNORMAL 8 0.0003
877 NEEDLE ISSUE 8 0.0003
878 MULTIPLE SCLEROSIS 13 0.0003
879 UNRESPONSIVE TO STIMULI 7 0.0003
880 LABORATORY TEST ABNORMAL 8 0.0003
881 BLOOD GLUCOSE DECREASED 13 0.0003
882 JOINT STIFFNESS 7 0.0003
883 HOSPITALISATION 41 0.0003
884 LOSS OF CONSCIOUSNESS 34 0.0003
885 PULMONARY EMBOLISM 25 0.0003
886 AMNESIA 17 0.0003
887 SKIN EXFOLIATION 22 0.0003
888 PAIN OF SKIN 7 0.0003
889 HAEMORRHAGE 27 0.0003
890 ABDOMINAL DISCOMFORT 43 0.0003
891 CHOKING 5 0.0003
892 RECTAL HAEMORRHAGE 11 0.0003
893 INFLUENZA LIKE ILLNESS 21 0.0003
894 BLOOD PRESSURE INCREASED 39 0.0003
895 RESPIRATORY ARREST 7 0.0003
896 DISEASE PROGRESSION 30 0.0003
897 FEELING COLD 7 0.0003
898 WOUND 7 0.0003
899 DRUG INEFFECTIVE 330 0.0003
900 SYNCOPE 25 0.0002
901 ADVERSE EVENT 23 0.0002
902 IRRITABILITY 15 0.0002
903 DIABETES MELLITUS 19 0.0002
904 HYPERHIDROSIS 32 0.0002
905 ASTHMA 28 0.0002
906 SUICIDE ATTEMPT 15 0.0002
907 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
908 OVERDOSE 52 0.0002
909 MIGRAINE 23 0.0002
910 URINARY RETENTION 8 0.0002
911 UNEVALUABLE EVENT 18 0.0002
912 SKIN BURNING SENSATION 17 0.0002
913 FLUSHING 24 0.0002
914 COMPLETED SUICIDE 19 0.0002
915 DRUG INTOLERANCE 22 0.0002
916 HOT FLUSH 17 0.0002
917 LIVER DISORDER 10 0.0002
918 DRY SKIN 30 0.0002
919 GLOSSODYNIA 5 0.0002
920 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 40 0.0002
921 AGGRESSION 11 0.0002
922 ABDOMINAL PAIN UPPER 45 0.0002
923 CEREBROVASCULAR ACCIDENT 37 0.0002
924 MOVEMENT DISORDER 7 0.0002
925 WITHDRAWAL SYNDROME 9 0.0002
926 ILL-DEFINED DISORDER 13 0.0002
927 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
928 TYPE 2 DIABETES MELLITUS 7 0.0002
929 DEVICE DISLOCATION 9 0.0002
930 PSORIASIS 27 0.0002
931 CEREBRAL INFARCTION 5 0.0002
932 GASTRIC DISORDER 7 0.0002
933 ACCIDENTAL EXPOSURE TO PRODUCT 21 0.0002
934 ACUTE MYOCARDIAL INFARCTION 6 0.0002
935 DYSPEPSIA 20 0.0002
936 RHEUMATOID ARTHRITIS 23 0.0002
937 CARDIAC FAILURE CONGESTIVE 16 0.0002
938 THROMBOSIS 16 0.0002
939 SOMNOLENCE 40 0.0002
940 CORONARY ARTERY DISEASE 6 0.0002
941 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
942 ALOPECIA 38 0.0002
943 DRUG DEPENDENCE 31 0.0002
944 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
945 NERVOUSNESS 10 0.0002
946 TOXICITY TO VARIOUS AGENTS 32 0.0002
947 OSTEONECROSIS 6 0.0002
948 CARDIAC DISORDER 17 0.0002
949 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
950 WEIGHT INCREASED 40 0.0002
951 FLATULENCE 10 0.0002
952 THERAPY CESSATION 9 0.0002
953 ABORTION SPONTANEOUS 7 0.0002
954 HYPERSOMNIA 5 0.0002
955 ROAD TRAFFIC ACCIDENT 7 0.0002
956 DRUG EFFECT INCOMPLETE 6 0.0002
957 ABDOMINAL DISTENSION 17 0.0002
958 INCORRECT DOSE ADMINISTERED 37 0.0002
959 DRY MOUTH 13 0.0002
960 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
961 UNDERDOSE 11 0.0002
962 PRODUCT STORAGE ERROR 13 0.0001
963 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
964 DEATH 127 0.0001
965 INFUSION RELATED REACTION 9 0.0001
966 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
967 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
968 ACNE 10 0.0001
969 SKIN IRRITATION 6 0.0001
970 EXPOSURE DURING PREGNANCY 8 0.0001
971 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
972 HAEMATOCHEZIA 7 0.0001
973 INTENTIONAL OVERDOSE 8 0.0001
974 DEVICE BREAKAGE 5 0.0001
975 MYOCARDIAL INFARCTION 21 0.0001
976 BLOOD CHOLESTEROL INCREASED 5 0.0001
977 NEOPLASM MALIGNANT 7 0.0001
978 INJECTION SITE ERYTHEMA 12 0.0001
979 PRODUCT QUALITY ISSUE 13 0.0001
980 DRUG EFFECT DECREASED 5 0.0001
981 INJECTION SITE PAIN 27 0.0001
982 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
983 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
984 BLOOD GLUCOSE INCREASED 15 0.0001
985 DRUG DOSE OMISSION 13 0.0001
986 INJECTION SITE SWELLING 6 0.0001
987 INJECTION SITE HAEMORRHAGE 6 0.0001
988 INJECTION SITE REACTION 5 0.0001
989 INJECTION SITE BRUISING 5 0.0001
990 BREAST CANCER 5 0.0001